Skip to main content

Advertisement

SpringerLink
Log in

Characteristics of colorectal cancer in the human immunodeficiency virus-infected African American population

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

Colorectal Cancer (CRC) is the second leading cause of cancer mortality in the United States. African Americans (AAs) have the highest incidence of CRC of any American ethnic group. Survival from CRC in AAs is lower than in Caucasians, and the mean age of CRC development in AAs is younger. The AA community also has a high rate of HIV infection, accounting for 50.3% of all cases despite making up only 13.6% of the population. This retrospective cohort study identified 17 AA HIV patients with CRC. The patients were matched with 42 HIV-negative CRC patients (controls), based on age, sex, and TNM stage. Data were obtained from 3 hospitals in New Jersey: St. Michael’s Medical Center, Trinitas Medical Center and St. Joseph’s Medical Center. The age, sex, HIV status, tumor site, stage, drug usage, Hepatitis C status, and survival outcome of subjects and controls were compared. Data from the Surveillance Epidemiology & End Results (SEER) specific to AAs were also compared. The mean age of CRC diagnosis was younger, 50.7 years (median: 52 years, range: 35–71 years), versus 59.42 years (median: 66 years) (P < 0.0001) in the SEER AA population. Of the patients, 29.4% were diagnosed with CRC at less than 45 years of age, versus only 6.35% of the SEER AA population (P < 0.0002). The male-to-female ratio was 11:6. Seven individuals used IV drugs, and 7 had hepatitis C. The mean CD4+ T-cell count was 510.81 cells/mm3 (median 419). At the time of CRC diagnosis, the average duration of HIV infection was 7.6 years (range 0–22.4 years).Of patients, 87.5% had left-sided CRC, versus 57.55% of the SEER population (P < 0.024). Of the patients, 52.94% had stage III–IV, at diagnosis, versus 43.84% in SEER. There was no statistically significant survival difference between the cases and controls. In our cohort of HIV-infected AA’s with CRC, the staging and outcome of CRC did not appear to be affected by the degree of immunosuppression. HIV-infected AA with CRC presented with a higher percentage of left-sided CRC than AA’s without HIV. Additionally, AAs with HIV tended to be younger at the time of CRC diagnosis. Our findings suggest that screening for CRC should be offered to HIV-infected AAs before the age of 45, and that sigmoidoscopy with fecal occult blood testing might be an acceptable screening modality. However, the exact age of initiation, optimal frequency, and preferred method of screening (colonoscopy vs. sigmoidoscopy) in this population requires further study.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Oramasionwu CU, Brown CM, et al. HIV/AIDS disparities: the mounting epidemic plaguing US blacks. J Natl Med Assoc. 2009;101(12):1196–204.

    PubMed  Google Scholar 

  2. Moore RD. Epidemiology of HIV infection in the United States: implications for Linkage to Care. Clin Infect Dis 52(Suppl 2):S208–13.

  3. McQuillan GM, Kruszon-Moran D, et al. Prevalence of HIV in the US household population: the National Health and Nutrition Examination Surveys, 1988 to 2002. J Acquir Immune Defic Syndr. 2006;41(5):651–6.

    Article  PubMed  Google Scholar 

  4. Shapiro MF et al. Variations in the care of HIV-infected adults in the United States. JAMA. 1999;281(24).

  5. Cunningham WE et al. The impact of competing subsistence needs and barriers to access to medical care for persons with human immunodeficiency virus receiving care in the United States. Medical Care. 1999;37(12).

  6. Palella FJ Jr, Deloria-Knoll M, Chmiel JS, et al. Survival benefit of initiating antiretroviral therapy in HIV infected persons in different CD4+ cell strata. Ann Intern Med. 2003;138:620–6.

    PubMed  Google Scholar 

  7. Mocroft A, Ledergerber B, Katlama C, et al. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet. 2003;362:22–9.

    Article  PubMed  CAS  Google Scholar 

  8. Ormaasen V, Sandvik L, et al. HIV related and non-HIV related mortality before and after the introduction of highly active antiretroviral therapy (HAART) in Norway compared to the general population. Scand J Infect Dis. 2007;39(1):51–7.

    Article  PubMed  Google Scholar 

  9. Bedimo R, Chen RY, Accortt NA, et al. Trends in AIDS-defining and non-AIDS defining malignancies among HIV-infected patients: 1989–2002. Clin Infect Dis. 2004;39:1380–4.

    Article  PubMed  Google Scholar 

  10. Biggar RJ, Chaturvedi AK, Goedert JJ, et al. AIDS-related cancer and severity of immunosuppression in persons with AIDS. J Natl Cancer Inst. 2007;99:962–72.

    Article  PubMed  Google Scholar 

  11. Krentz HB, Kliewer G, Gill MJ. Changing mortality rates and causes of death for HIV infected individuals living in Southern Alberta, Canada from 1984 to 2003. HIV Med. 2005;6:99–106.

    Article  PubMed  CAS  Google Scholar 

  12. Sackoff JE, Hanna DB, Pfeiffer MR, et al. Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. Ann Intern Med. 2006;145:397–406.

    PubMed  Google Scholar 

  13. Phatak UA, Joshi R, et al. AIDS-associated cancers: an emerging challenge. J Assoc Physicians India. 58:159–62.

  14. Grulich AE, Wan X, Law MG, et al. Risk of cancer in people with AIDS. AIDS. 1999;13:839–43.

    Article  PubMed  CAS  Google Scholar 

  15. Hessol NA, Pipkin S, Schwarcz S, et al. The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS. Am J Epidemiol. 2007;165:1143–53.

    Article  PubMed  Google Scholar 

  16. Mitsuyasu RT. Non-AIDS-defining malignancies in HIV. Top HIV Med. 2008;16(4):117–21.

    PubMed  Google Scholar 

  17. Silverberg MJ, Abrams DI. AIDS-defining and non-AIDS-defining malignancies: cancer occurrence in the antiretroviral therapy era. Curr Opin Oncol. 2007;19(5):446–51.

    PubMed  Google Scholar 

  18. Rise LAG, Eisner MP, Kosary CL, et al. Editors. SEER cancer statistics review, 1975–2000. Bethesda (MD): National Cancer Institute, http://www.seer.cancer.gov/csr/1975–2000, 2003.

  19. Parker SL, Davis KJ, Wingo PA, et al. Cancer statistics by race and ethnicity. Ca Cancer J Clinic. 1998;48:31–48.

    Article  CAS  Google Scholar 

  20. Theuer CP, Wagner JL, Taylor TH, et al. Racial & ethnic colorectal cancer patterns affect the cost-effectiveness of colorectal cancer screening in the United States. Gastroenterology. 2001;120:848–56.

    Article  PubMed  CAS  Google Scholar 

  21. Cress RD, Morris CR, Wolfe BM. Cancer of the colon and rectum in California: trends in incidence by race/ethnicity, stage, and subsite. Prev Med. 2003;31:447–53.

    Article  Google Scholar 

  22. Chatter-Cora D, Onime GD, Valentine IS, et al. Colorectal cancer in a multi-ethnic urban group: its anatomical and age profile. Int Surg. 2000;85:137–42.

    Google Scholar 

  23. Johnson H, Carstens R. Anatomic distribution of colonic carcinomas. Interracial differences in community hospital population. Cancer. 1986;58:997–1000.

    Article  PubMed  Google Scholar 

  24. Rex DK, Johnson DA, et al. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol. 2009;104(3):739–50.

    Article  PubMed  Google Scholar 

  25. Agrawal S, Bhupinderjit A, et al. Colorectal cancer in African Americans. Am J Gastroenterol. 2005;100(3):515–23. discussion 514.

    Article  PubMed  Google Scholar 

  26. McAlearney AS, Reeves KW, et al. Racial differences in colorectal cancer screening practices and knowledge within a low-income population. Cancer. 2008;112(2):391–8.

    Article  PubMed  Google Scholar 

  27. Ruffin MTT, Creswell JW, et al. Factors influencing choices for colorectal cancer screening among previously unscreened African and Caucasian Americans: findings from a triangulation mixed methods investigation. J Community Health. 2009;34(2):79–89.

    Article  PubMed  Google Scholar 

  28. Sharma S, O’Keefe SJ. Environmental influences on the high mortality from colorectal cancer in African Americans. Postgrad Med J. 2007;83(983):583–9.

    Article  PubMed  Google Scholar 

  29. McAlexander KM, Banda JA, et al. Physical activity resource attributes and obesity in low-income African Americans. J Urban Health. 2009;86(5):696–707.

    Article  PubMed  Google Scholar 

  30. Cunningham WE, Andersen RM, et al. The impact of competing subsistence needs and barriers on access to medical care for persons with human immunodeficiency virus receiving care in the United States. Med Care. 1999;37(12):1270–81.

    Article  PubMed  CAS  Google Scholar 

  31. Sankila R, Aaltonen LA, Jarvinen HJ, et al. Better survival rates in patients with MLH1-associated hereditary colorectal cancer. Gastroenterology. 1996;119:682–7.

    Article  Google Scholar 

  32. Wasserberg N, Nunoo-Mensah JW, et al. Colorectal cancer in HIV-infected patients: a case control study. Int J Colorectal Dis. 2007;22(10):1217–21.

    Article  PubMed  Google Scholar 

  33. Yeguez JF, Martinez S, Sands D, Sands LR, Hellinger MD. Colorectal malignancies in HIV-positive patients. Am Surg. 2003;11:981–7.

    Google Scholar 

  34. Berretta M, Tirelli U. Colorectal cancer screening in HIV-infected patients 50 years of age and older: missed opportunities for prevention. Am J Gastroenterol. 2006;101:907–8.

    Article  PubMed  Google Scholar 

  35. Berretta M, Cappellani A, et al. Clinical presentation and outcome of colorectal cancer in HIV-positive patients: a clinical case-control study. Onkologie. 2009;32(6):319–24.

    Article  PubMed  Google Scholar 

  36. Bini EJ, Park J, Francois F. Use of flexible sigmoidoscopy to screen for colorectal cancer in HIV-infected patients 50 years of age and older. Arch Intern Med. 2006;166:1626–31.

    Article  PubMed  Google Scholar 

  37. Reinhold JP, Moon M, et al. Colorectal cancer screening in HIV-infected patients 50 years of age and older: missed opportunities for prevention. Am J Gastroenterol. 2005;100(8):1805–12.

    Article  PubMed  Google Scholar 

  38. Taylor V, Lessler D, Mertens K, et al. Colorectal cancer screening among African Americans: the importance of physician recommendation. J Natl Med Assoc. 2003;95:806–12.

    PubMed  Google Scholar 

  39. Powe BD. Perceptions of cancer fatalism among African Americans: the influence of education, income, and cancer knowledge. J Natl Black Nurses Assoc. 1994;7:41–8.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Saint Michael’s Medical Center, Newark, NJ, USA

    Avishek Kumar, Nihar Shah, Yashpal Modi & Vincent A. DeBari

  2. Department of Internal Medicine, Trinitas Regional Medical Center, Elizabeth, NJ, USA

    Swaroopa Yerrabothala

  3. Department of Gastroenterology, Saint Michael’s Medical Center, Newark, NJ, USA

    Joseph DePasquale

  4. Department of Hematology and Oncology, St. Joseph’s Regional Medical Center, Paterson, NJ, USA

    Michael Maroules

  5. Department of Hematology and Oncology, Saint Michael’s Medical Center, Newark, NJ, USA

    Hamid S. Shaaban & Gunwant K. Guron

  6. School of Health and Medical Sciences, Seton Hall University, South Orange, NJ, USA

    Avishek Kumar, Nihar Shah, Yashpal Modi, Hamid S. Shaaban, Joseph DePasquale, Vincent A. DeBari, Swaroopa Yerrabothala, Michael Maroules & Gunwant K. Guron

Authors
  1. Avishek Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nihar Shah
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yashpal Modi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hamid S. Shaaban
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Joseph DePasquale
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Vincent A. DeBari
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Swaroopa Yerrabothala
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Michael Maroules
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Gunwant K. Guron
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Avishek Kumar.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kumar, A., Shah, N., Modi, Y. et al. Characteristics of colorectal cancer in the human immunodeficiency virus-infected African American population. Med Oncol 29, 1773–1779 (2012). https://doi.org/10.1007/s12032-011-0015-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12032-011-0015-9

Keywords

Search

Navigation